PATH | VRL
Menu

Find resources

Total results with these characteristics: 1340

Topic: Disease/vaccine specific information

Page 64 of 67
The Unrecognized Burden of Typhoid Fever

This article, published in Expert Review of Vaccines, provides an overview of the gaps in current estimates of typhoid fever disease burden and offers suggestions for addressing them so that affected communities can receive the full potential of …

Author: Obaro SK, Iroh Tam PY, Mintz ED

Publication date: 2017

Update on Intussusception Following Rotavirus Vaccine Administration

This web page provides an extract of a report on the World Health Organization's Global Advisory Committee on Vaccine Safety (GACVS) meeting held in December 2013 where the committee reviewed new data from Australia and the United States regarding …

Author: World Health Organization

Publication date: 2014

An Update on Vaccination Against Group B Streptococcus

This article, published in Expert Review of Vaccines, examines the vaccine development pipeline for group B Streptococcus (GBS). The authors note that a number of candidates have the potential to be successful, but that there are issues still to be …

Author: Heath PT

Publication date: 2011

Updated Estimation of the Impact of a Japanese Encephalitis Immunization Program With Live, Attenuated SA 14-14-2 Vaccine in Nepal

This article, published in PLoS Neglected Tropical Diseases, describes the impact of the Japanese encephalitis (JE) immunization program in Nepal using SA 14-14-2 JE vaccine from 2006 to 2011. A previous assessment after the initial program …

Author: Upreti SR, Lindsey NP, Bohara R, et al.

Publication date: 2017

Uptake of the Human Papillomavirus Vaccine in Kenya: Testing the Health Belief Model Through Pathway Modeling on Cohort Data

This article, published in Globalization and Health, reports the results of a study that investigated the utility of the Health Belief Model (HBM) in predicting uptake of human papillomavirus (HPV) vaccine in Kenya. The data demonstrated that …

Author: Vermandere H, van Stam M-A, Naanyu V, Michielsen K, Degomme O, Oort F

Publication date: 2016

US Department of Defense and PATH: Working Together to Advance Global Health Innovations

This fact sheet describes the partnership between PATH and the US Department of Defense (DoD). It highlights PATH projects—including the development of vaccines against enterotoxigenic Escherichia coli, Shigella, and malaria, along with work on …

Author: PATH

Publication date: 2016

US Department of Health and Human Services and PATH: Partnering to Protect and Improve Global Health

PATH and the US Department of Health and Human Services (HHS) work together to improve global health around the world. This fact sheet highlights PATH projects—including work to develop a thermostable vaccine for H1N1 influenza; ROTAVAC®, a new …

Author: PATH

Publication date: 2014

The US Government and Global Polio Efforts

This fact sheet provides an overview of the US government's political, financial, and technical support for the global eradication of polio. It includes a current snapshot of global polio, including the burden of disease and the status of …

Author: The Henry J. Kaiser Family Foundation

Publication date: 2016

USAID and PATH: Working Together to Improve Global Health

This fact sheet describes the partnership between PATH and the US Agency for International Development (USAID) to improve global health around the world. It covers work supported by USAID across several of PATH’s platforms, including the …

Author: PATH

Publication date: 2014

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

This article, published in Morbidity and Mortality Weekly Report, outlines the recommendation by the Advisory Committee on Immunization Practices (ACIP) to include the 9-valent human papillomavirus (HPV) vaccine as one of the three HPV vaccines that …

Author: US Centers for Disease Control and Prevention

Publication date: 2015

Use of MenAfriVac™ (Meningitis A Vaccine) in a Controlled Temperature Chain (CTC) During Campaigns

The need to keep vaccines in a 2°C to 8°C cold chain is a constraining factor for many immunization campaigns due to limited storage capacity and/or ice pack freezing capacity. In 2012, based on a thorough review of scientific data by regulatory …

Author: World Health Organization

Publication date: 2013

Use of Quantitative Molecular Diagnostic Methods to Identify Causes of Diarrhoea in Children: A Reanalysis of the GEMS Case-Control Study

This article, published in The Lancet, reports the results of a study that reanalyzed the Global Enteric Multicenter Study data to identify the leading causes of diarrhea in children under five years of age in sub-Saharan Africa and south Asia. The …

Author: Liu J, Platts-Mills JA, Juma J, et al.

Publication date: 2016

Use of Vaccines Outside of the Cold Chain: A Literature Review

This review compiles the literature available on the use of vaccines outside of the cold chain. Most of the studies analyzed in this review focus on hepatitis B, except one that examines meningococcal Group C vaccine. Most showed that there are no …

Author: PATH, World Health Organization

Publication date: 2008

Using Innovation to Combat Diarrheal Disease in Vietnam

This fact sheet describes a PATH project in Vietnam that is focusing on testing a new formulation of a locally made rotavirus vaccine. PATH, Vietnam-based manufacturer POLYVAC (Center for Research and Production of Vaccines and Biologicals), and …

Author: PATH

Publication date: 2019

Vaccination Against Enterotoxigenic Escherichia coli, A Cause of Travelers' Diarrhea

This review, published in The Journal of Travel Medicine, focuses on the strategies behind development and potential use of currently available vaccines and vaccine candidates against enterotoxigenic Escherichia coli (ETEC) infection. As …

Author: Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N

Publication date: 2005

Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality?

This article, published in The Lancet Infectious Diseases, describes the epidemiological and immunological background of respiratory syncytial virus (RSV) infection and the pipeline of RSV vaccines in development. It discusses the potential for …

Author: Saso A, Kampmann B

Publication date: 2016

The Vaccine and Cervical Cancer Screen (VACCS) Project: Acceptance of Human Papillomavirus Vaccination in a School-Based Programme in Two Provinces of South Africa

This article, published in the South African Medical Journal, investigated the acceptance of a school-based human papillomavirus (HPV) vaccination delivery strategy. The results demonstrated that HPV vaccination is practical and safe in South …

Author: Botha MH, van der Merwe FH, Snyman LC, Dreyer G.

Publication date: 2015

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

This article, published in the New England Journal of Medicine, describes a multinational, Phase 3, observer-blinded study evaluating the efficacy of quadrivalent influenza vaccine (QIV) among children three to eight years of age. From the study …

Author: Jain VK, Rivera L, Zama Khalequ, et al.

Publication date: 2013

Vaccine Information Statements

This page contains vaccine information statements for a variety of immunizations, which are published by the US Centers for Disease Control and Prevention. This web page also includes links to translations of the statements to many languages other …

Author: Immunization Action Coalition

Vaccine Information Statements

Vaccine Information Statements (VISs) are information sheets used in the United States (US) that explain both the benefits and risks of a vaccine to vaccine recipients. US federal law requires that healthcare staff provide a VIS to a patient, …

Author: US Centers for Disease Control and Prevention

Page 64 of 67